April 22, 2021 7:01 AM EDT
Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.
LAS VEGAS, NV / ACCESSWIRE / April 22, 2021 / CLS Holdings USA, Inc. (OTCQB: CLSH)(CSE: CLSH), the ”Company” or ”CLS”, a diversified cannabis company operating as Cannabis Life Sciences, today announced that it has amended the terms of $6,229,672 in principal amount, which includes capitalized interest, of its outstanding unsecured convertible debentures (the “U.S. Debentures”) issued October 25, 2018 and October 31, 2018 by, among other things, (i) reducing the conversion price from $0.80 per unit to $0.30 per unit; and (ii) extending the maturity date of the U.S. Debentures by one year to four (4) years from the execution date of the U.S. Debentures. The exercise price of the warrants issuable upon conversion of the U.S. Debentures remains unchanged. The amendments also